Yingshi G. Zhang
No. 103 Wenhua Road
Shenyang, 110016, China
Shenyang, 110016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
What are the beneficial treatment strategies in maintaining T lymphocyte subsets after cancer surgery? A systematic review and network meta-analysis.
Journal: Frontiers in immunology
Published: April 13, 2026
Prophylactic use of antiepileptics in spontaneous intracerebral hemorrhage: a systematic review and meta-analysis focusing on early seizures and clinical determinants.
Journal: Neurosurgical review
Published: February 22, 2026
Multi-Targeted Therapeutic Mechanisms of Huangqi Guizhi Wuwu Decoction Against Rheumatoid Arthritis: An Integrated Approach Combining Serum Pharmacochemistry, Network Pharmacology, Metabolomics, and Experimental Validation.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 20, 2025
Fluorocyclopropyl-Containing Tacrine Derivatives as Potent and Selective Dual CDK2/CDK9 Inhibitors for the Treatment of Colorectal Cancer.
Journal: Journal of medicinal chemistry
Published: November 15, 2025
The role of ADAM8 in intrahepatic cholangiocarcinoma.
Journal: Discover oncology
Published: October 21, 2025
Role of basic chemistry education in clinical pharmacy requirements: evidence from cross-sectional study and narrative review.
Journal: BMC medical education
Published: May 20, 2025
Editorial Expression of Concern: A novel 4-aminoquinazoline derivative, DHW-208, suppresses the growth of human breast cancer cells by targeting the PI3K/AKT/mTOR pathway.
Journal: Cell death & disease
Published: March 28, 2025
Efficacy and safety of glucagon-like peptide-1 receptor agonists in the treatment of polycystic ovary syndrome-A systematic review and meta-analysis.
Journal: Archives of physiology and biochemistry
Published: July 31, 2024
Which is the best TACE agent for patients with different NLR hepatocellular carcinomas? A systematic review and network meta-analysis.
Journal: Heliyon
Published: October 31, 2023
The ADAM17 inhibitor ZLDI-8 sensitized hepatocellular carcinoma cells to sorafenib through Notch1-integrin β-talk.
Journal: Pharmacological research
Published: October 25, 2023
Last Updated: 09/26/2026